The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions
Experience.
History-Making.
DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity
How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
What strategies are being employed to accelerate product development and commercialization without compromising quality?
The Most Significant Regulatory Decision or Guidance on the Horizon for 2024 (or Beyond)?
The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023
Reach the Patient Quicker with GBI’s Manufacturing Solutions
